The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature.
Benign prostatic hyperplasia
GreenLight XPS
Lower urinary tract symptoms
Photovaporization of the prostate
Small prostate
Journal
Asian journal of urology
ISSN: 2214-3882
Titre abrégé: Asian J Urol
Pays: Singapore
ID NLM: 101699720
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
24
04
2018
revised:
23
08
2018
accepted:
17
10
2018
entrez:
27
11
2019
pubmed:
27
11
2019
medline:
27
11
2019
Statut:
ppublish
Résumé
Our objective was to characterize the safety and efficacy of the 180 W XPS-GreenLight laser in men with lower urinary tract symptoms secondary to a small volume benign prostatic hyperplasia (BPH). A retrospective analysis was performed for all patients who underwent 180 W XPS-laser photoselective vaporization of the prostate (PVP) vaporization of the prostate between 2012 and 2016 at two-tertiary medical centers. Data collection included baseline comorbidities, disease-specific quality of life scores, maximum urinary flow rate (Q Mean age of men was 67.8 years old, with a mean body mass index of 29.7 kg/m The 180 W GreenLight XPS system is safe and effective for men with small volume BPH. PVP produced improvements in symptomatic and clinical parameters without any safety concern. It represents a safe surgical option in this under studied population.
Identifiants
pubmed: 31768321
doi: 10.1016/j.ajur.2019.01.006
pii: S2214-3882(19)30007-4
pmc: PMC6872824
doi:
Types de publication
Journal Article
Langues
eng
Pagination
353-358Informations de copyright
© 2019 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V.
Références
Rev Urol. 2003;5 Suppl 4:S12-7
pubmed: 16985958
BJU Int. 2009 Aug;104(4):434-6
pubmed: 19338541
Eur Urol. 2007 Nov;52(5):1456-63
pubmed: 17499427
Eur Urol. 2014 May;65(5):931-42
pubmed: 24331152
PLoS One. 2016 May 26;11(5):e0156133
pubmed: 27227564
Urology. 2013 Mar;81(3):634-9
pubmed: 23332997
J Urol. 2012 Nov;188(5):1746-53
pubmed: 22998906
J Endourol. 2016 Aug;30(8):906-12
pubmed: 27203515
World J Mens Health. 2017 Dec;35(3):163-169
pubmed: 29164833
Urology. 2013 Aug;82(2):416-22
pubmed: 23791215
J Urol. 2011 May;185(5):1793-803
pubmed: 21420124
J Urol. 2014 Jan;191(1):148-54
pubmed: 23845460
J Urol. 2005 Jul;174(1):210-4
pubmed: 15947629
Urol Clin North Am. 2016 Aug;43(3):351-6
pubmed: 27476127
J Urol. 2015 Aug;194(2):462-9
pubmed: 25849599
Eur Urol. 2008 Oct;54(4):893-901
pubmed: 18486311
BJU Int. 2012 Dec;110(11):1595-601
pubmed: 22540956
J Urol. 2008 Jul;180(1):246-9
pubmed: 18499179
J Endourol. 2017 Nov;31(11):1189-1194
pubmed: 28844169
J Urol. 2013 Jan;189(1 Suppl):S141-5
pubmed: 23234620
BJU Int. 2016 Oct;118(4):633-40
pubmed: 26970202
Nat Rev Dis Primers. 2016 May 05;2:16031
pubmed: 27147135
World J Mens Health. 2013 Apr;31(1):64-9
pubmed: 23658868
Can J Urol. 2013 Feb;20(1):6633-9
pubmed: 23433136
J Urol. 2011 Feb;185(2):712-8
pubmed: 21168876
Eur Urol. 2012 Feb;61(2):341-9
pubmed: 22074761
Eur Urol. 2007 Nov;52(5):1463
pubmed: 17499426
Expert Opin Emerg Drugs. 2017 Sep;22(3):201-212
pubmed: 28829208
BJU Int. 2010 Apr;105(7):964-9
pubmed: 19912196
Eur Urol. 2010 Sep;58(3):349-55
pubmed: 20605316
Urology. 2011 Jul;78(1):134-40
pubmed: 21550638